HEAD AND NECK CANCERS
Clinical trials for HEAD AND NECK CANCERS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early cancer trial halted after testing new drug combo
Disease control TerminatedThis early-stage study aimed to see if it was safe to add a new immunotherapy drug called durvalumab to a standard three-drug chemotherapy regimen for patients with advanced head and neck cancer that had not spread. The main goal was to find the safest dose for future testing and…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
App aims to ease depression for cancer survivors, but study stops early
Symptom relief TerminatedThis study aimed to test a smartphone app designed to help head and neck cancer survivors manage symptoms of depression. Participants were asked to use the mental health app for six weeks and complete surveys. The study was terminated early after enrolling only one person, so its…
Matched conditions: HEAD AND NECK CANCERS
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC